Skip to main content

Table 3 Subject’s Medication at Baseline

From: The implementation of a community-based aerobic walking program for mild to moderate knee osteoarthritis (OA): a knowledge translation (KT) randomized controlled trial (RCT): Part I: The Uptake of the Ottawa Panel clinical practice guidelines (CPGs)

Medication Walking (W) only (n=79) Walking and Behavioural (WB) (n=69) Self-directed (C) (n=74)
Oral hypoglycaemic agents    
  Total 2 (3) 5 (7) 9 (12)
  Biguanide Class 2 (3) 4 (6) 9 (12)
  Sulfonylureas Class 0 (0) 0 (0) 2 (3)
  Thiazolidinedione 0 (0) 2 (3) 2 (3)
Antihypertensive Agents    
  Total 22 (28) 15 (22) 15 (22)
  Calcium channel blockers 6(8) 0(0) 7(9)
  Antiotensin-converting enzyme 3 (4) 7 (10) 7 (9)
  Angiotensin II receptor blockers 6 (8) 6 (9) 3 (4)
  Beta-blocker 4 (5) 3 (4) 4 (5)
  Alpha-blocker 3 (4) 0 (0) 0 (0)
  Diuretic 5 (6) 8 (12) 5 (7)
Antiarrhythmic 1 (1) 0 (0) 0 (0)
Anti-anginal 1 (1) 0 (0) 0 (0)
Anti-platelet agent 1 (1) 1 (1) 1 (1)
Anticoagulant 0 (0) 2 (3) 0 (0)
Phosphodiesterase type 5 inhibitors 0 (0) 1 (1) 0 (0)
Statins 8 (10) 12 (17) 10 (14)
Hormone    
  Total 11 (14) 10 (14) 11 (15)
  Thyroid 5 (6) 5 (7) 8 (11)
  Insulin 0 (0) 3 (4) 1 (1)
  Corticosteroid 4 (5) 2 (3) 3 (4)
  Progesterone 1 (1) 0 (0) 1 (1)
  Androgen 1 (1) 0 (0) 0 (0)
  Oestrogen 1 (1) 0 (0) 0 (0)
Antithyroid 0 (0) 1 (1) 0(0)
SERMs (Selective estrogen receptor modifiers) 1 (1) 0 (0) 0 (0)
Beta 2-adrenergic receptor agonist (bronchodilator) 2(3) 1 (1) 3 (4)
NSAIDs (Non-steroid anti-inflammatory drugs) 26 (33) 21 (30) 18 (24)
COX-2 selective inhibitor 3 (4) 4 (6) 1 (1)
NSAIDS    
Betahistine 0 (0) 1 (1) 0 (0)
DMARDs (Disease modifying antirheumatic drugs) 0 (0) 1 (1) 0 (0)
Histamine antagonist 0 (0) 2 (3) 0 (0)
Bisphosphonate 6 (8) 4 (6) 4 (5)
Antibiotics 2 (3) 1 (1) 4 (5)
Analgesics 1 (1) 1 (1) 3 (4)
Opiates 0 (0) 0 (0) 2 (3)
Hypnotic 4 (5) 3 (4) 4 (5)
Antidepressant 7 (9) 5 (7) 7 (9)
Psychostimulant 0 (0) 1 (1) 0 (0)
Antipsychotic 0 (0) 1 (1) 0 (0)
Anti-manic 0 (0) 1 (1) 0 (0)
Anti-convulsant 1 (1) 1 (1) 0 (0)
Protein pump inhibitor (PPI) 9 (11) 5 (6) 6 (8)
Enzyme inhibitor 0 (0) 1 (1) 2 (3)
Muscle relaxant 0 (0) 1 (1) 1 (1)
Antispasmodic 0 (0) 1 (1) 0 (0)
Anti-cholinergic 1 (1) 1 (1) 0 (0)
Antineoplastic 2 (3) 1 (1) 0 (0)
Antimetabolite 1 (1) 1 (1) 1 (1)
Antifolate 0 (0) 1 (1) 1 (1)
Latanoprost 0 (0) 1 (1) 0 (0)
Viscosupplementation 0 (0) 1 (1) 0 (0)
Xanthine 1 (1) 0 (0) 0 (0)
Antifungals 0 (0) 0 (0) 1 (1)
Antimalarial 0 (0) 1 (1) 1 (1)
Nitrate 0 (0) 0 (0) 2 (3)
Laxative 0 (0) 0 (0) 2 (3)
Supplements 22 (28) 22 (28) 18 (24)
Homeopathic Medication 1 (1) 1 (1) 1 (1)
None 11 (14) 10 (13) 9 (12)
Not Specific 21 (27) 21 (27) 20 (27)
Missing Data    
  Total 4 (5) 8 (10) 17 (23)
  No Evaluation* 2 (3) 4 (5) 7 (9)
  No File** 2 (3) 4 (6) 10 (14)
  1. This table presents a list of medications which participants declared to be taking at baseline. Data is presented as n (%).